Skip to main content
Clinical Trials/NCT05461027
NCT05461027
Completed
Not Applicable

Percutaneous Cryoablation of Central Kidney Tumours With Temporary Renal Artery Occlusion

University Hospital, Strasbourg, France1 site in 1 country16 target enrollmentMay 1, 2022
ConditionsKidney Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Kidney Cancer
Sponsor
University Hospital, Strasbourg, France
Enrollment
16
Locations
1
Primary Endpoint
Description of the technique of percutaneous cryoablation of central renal tumours with temporary balloon obliteration of the renal artery
Status
Completed
Last Updated
last year

Overview

Brief Summary

Percutaneous cryoablation is an alternative to urological surgery for T1a tumours, whose oncological efficacy decreases for the most central tumours due to a cold sink effect.

Registry
clinicaltrials.gov
Start Date
May 1, 2022
End Date
December 31, 2023
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
University Hospital, Strasbourg, France
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Description of the technique of percutaneous cryoablation of central renal tumours with temporary balloon obliteration of the renal artery

Time Frame: Files analysed retrospectively from January 01, 2018 to December 31, 2021 will be examined

Study Sites (1)

Loading locations...

Similar Trials